<DOC>
	<DOCNO>NCT00000819</DOCNO>
	<brief_summary>To determine efficacy safety prednisone patient HIV-associated nephropathy . To determine effect prednisone serum creatinine , urinary protein , creatinine clearance . HIV-associated nephropathy characterize heavy proteinuria , rapidly progressive renal insufficiency , distinct nephropathologic change . The syndrome often occur patient advanced HIV disease . Little known effect corticosteroid progression HIV disease . In light possible beneficial effect corticosteroid HIV-associated nephropathy , control trial use prednisone warrant .</brief_summary>
	<brief_title>A Phase II Randomized , Double-Blind , Placebo-Controlled Trial Determine Efficacy Prednisone Therapy HIV-Associated Nephropathy ( HIVAN )</brief_title>
	<detailed_description>HIV-associated nephropathy characterize heavy proteinuria , rapidly progressive renal insufficiency , distinct nephropathologic change . The syndrome often occur patient advanced HIV disease . Little known effect corticosteroid progression HIV disease . In light possible beneficial effect corticosteroid HIV-associated nephropathy , control trial use prednisone warrant . Patients randomize receive prednisone placebo 11 week , follow 13 week observation .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>AIDS-Associated Nephropathy</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<criteria>Inclusion Criteria Patients must : HIV infection . Biopsyconfirmed glomerulosclerosis and/or mesangial proliferation within 90 day prior study entry . Mild severe renal insufficiency stable worsening . No AIDSdefining opportunistic infection malignancy . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Poorly control hypertension diabetes mellitus . Peptic ulcer disease gastrointestinal bleeding . Active symptomatic bacterial , protozoal , fungal , viral infection ( HIV disease ) . Superimposed renal disease due process focal glomerulosclerosis mesangial proliferation , include limited obstructive uropathy , acute tubular necrosis , prerenal azotemia . Emotional problem sufficient prevent adequate compliance study therapy . Concurrent Medication : Excluded : IV amphotericin B. IV aminoglycosides . IV foscarnet . IV pentamidine . Trimethoprim &gt; 200 mg/day . Nonsteroidal antiinflammatory agent . Angiotensin convert enzyme inhibitor ( benzapril , captopril , enalapril , fosinopril , lisinopril , guinapril , ramipril ) except refractory hypertension . Concurrent Treatment : Excluded : Iodinated radiocontrast dye . Patients follow prior condition exclude : Active pulmonary disease chest radiograph within 60 day prior study entry . CMV retinitis ophthalmologic evaluation within 60 day prior study entry . Positive blood culture mycobacteria 1060 day prior study entry . Prior Medication : Excluded : Prior corticosteroid therapy HIVAN . Corticosteroid therapy indication within 30 day prior study entry . Continuous nonsteroidal antiinflammatory agent 15 day 4 week prior study entry . Prior Treatment : Excluded within 30 day prior study entry : Dialysis acute chronic renal failure . Iodinated radiocontrast dye . Required : Stable antiretroviral therapy AZT alone combination ddI , ddC , d4T least 4 week unless contraindicate . PCP prophylaxis TMP/SMX , pentamidine aerosol , dapsone , atovaquone . MAC prophylaxis rifabutin clarithromycin patient CD4 count &lt; 100 cells/mm3 . Mycobacterium tuberculosis prophylaxis isoniazid another accepted regimen patient positive previously positive tuberculin test anergic patient know household close contact infectious TB patient group prevalence TB 10 percent high . Investigational drug unless exempt protocol chair . Other medication unless expressly prohibit . Active alcohol drug abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Prednisone</keyword>
	<keyword>AIDS-Associated Nephropathy</keyword>
</DOC>